Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage stimulating 1-like (MST1L) is classified as a pseudogene in humans, located on chromosome 1 and not known to produce a functional protein product. It is predicted, based on sequence analysis, to have potential molecular functions such as receptor tyrosine kinase binding and possible involvement in the JAK-STAT signaling pathway, but there is no experimental evidence confirming these activities or any biological roles. MST1L has several aliases reflecting its relationship to the macrophage-stimulating 1 (MST1) family, but, as a pseudogene, it is not considered a druggable therapeutic target or a known biomarker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage stimulating 1-like pseudogene (MST1L).